Systolic heart failure: a prothrombotic state

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Systolic heart failure: a prothrombotic state. / de Peuter, Olav R; Kok, Wouter E M; Torp-Pedersen, Christian; Büller, Harry R; Kamphuisen, Pieter W; de Peuter, Olav R; Kok, Wouter E M; Torp-Pedersen, Christian; Büller, Harry R; Kamphuisen, Pieter W.

In: Seminars in Thrombosis and Hemostasis, Vol. 35, No. 5, 01.07.2009, p. 497-504.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

de Peuter, OR, Kok, WEM, Torp-Pedersen, C, Büller, HR, Kamphuisen, PW, de Peuter, OR, Kok, WEM, Torp-Pedersen, C, Büller, HR & Kamphuisen, PW 2009, 'Systolic heart failure: a prothrombotic state', Seminars in Thrombosis and Hemostasis, vol. 35, no. 5, pp. 497-504. https://doi.org/10.1055/s-0029-1234145, https://doi.org/10.1055/s-0029-1234145

APA

de Peuter, O. R., Kok, W. E. M., Torp-Pedersen, C., Büller, H. R., Kamphuisen, P. W., de Peuter, O. R., Kok, W. E. M., Torp-Pedersen, C., Büller, H. R., & Kamphuisen, P. W. (2009). Systolic heart failure: a prothrombotic state. Seminars in Thrombosis and Hemostasis, 35(5), 497-504. https://doi.org/10.1055/s-0029-1234145, https://doi.org/10.1055/s-0029-1234145

Vancouver

de Peuter OR, Kok WEM, Torp-Pedersen C, Büller HR, Kamphuisen PW, de Peuter OR et al. Systolic heart failure: a prothrombotic state. Seminars in Thrombosis and Hemostasis. 2009 Jul 1;35(5):497-504. https://doi.org/10.1055/s-0029-1234145, https://doi.org/10.1055/s-0029-1234145

Author

de Peuter, Olav R ; Kok, Wouter E M ; Torp-Pedersen, Christian ; Büller, Harry R ; Kamphuisen, Pieter W ; de Peuter, Olav R ; Kok, Wouter E M ; Torp-Pedersen, Christian ; Büller, Harry R ; Kamphuisen, Pieter W. / Systolic heart failure: a prothrombotic state. In: Seminars in Thrombosis and Hemostasis. 2009 ; Vol. 35, No. 5. pp. 497-504.

Bibtex

@article{27b61420785d11df928f000ea68e967b,
title = "Systolic heart failure: a prothrombotic state",
abstract = "Systolic heart failure is a common syndrome whose incidence is expected to increase. Several treatment modalities, such as beta-blockers and angiotensin-converting enzyme inhibitors, improve survival. Whether antithrombotic treatment is effective remains to be elucidated, although observations suggest a prothrombotic state in heart failure. This article focuses on this prothrombotic state and discusses the risk of thromboembolic events, pathophysiological mechanisms, and the potential role of anticoagulant treatment.",
author = "{de Peuter}, {Olav R} and Kok, {Wouter E M} and Christian Torp-Pedersen and B{\"u}ller, {Harry R} and Kamphuisen, {Pieter W} and {de Peuter}, {Olav R} and Kok, {Wouter E M} and Christian Torp-Pedersen and B{\"u}ller, {Harry R} and Kamphuisen, {Pieter W}",
note = "Keywords: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Fibrinolytic Agents; Heart Failure, Systolic; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Pulmonary Embolism; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Thromboembolism; Warfarin",
year = "2009",
month = jul,
day = "1",
doi = "10.1055/s-0029-1234145",
language = "English",
volume = "35",
pages = "497--504",
journal = "Seminars in Thrombosis and Hemostasis",
issn = "0094-6176",
publisher = "Thieme Medical Publishers, Inc.",
number = "5",

}

RIS

TY - JOUR

T1 - Systolic heart failure: a prothrombotic state

AU - de Peuter, Olav R

AU - Kok, Wouter E M

AU - Torp-Pedersen, Christian

AU - Büller, Harry R

AU - Kamphuisen, Pieter W

AU - de Peuter, Olav R

AU - Kok, Wouter E M

AU - Torp-Pedersen, Christian

AU - Büller, Harry R

AU - Kamphuisen, Pieter W

N1 - Keywords: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anticoagulants; Aspirin; Fibrinolytic Agents; Heart Failure, Systolic; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Prognosis; Pulmonary Embolism; Randomized Controlled Trials as Topic; Receptors, Angiotensin; Renin-Angiotensin System; Thromboembolism; Warfarin

PY - 2009/7/1

Y1 - 2009/7/1

N2 - Systolic heart failure is a common syndrome whose incidence is expected to increase. Several treatment modalities, such as beta-blockers and angiotensin-converting enzyme inhibitors, improve survival. Whether antithrombotic treatment is effective remains to be elucidated, although observations suggest a prothrombotic state in heart failure. This article focuses on this prothrombotic state and discusses the risk of thromboembolic events, pathophysiological mechanisms, and the potential role of anticoagulant treatment.

AB - Systolic heart failure is a common syndrome whose incidence is expected to increase. Several treatment modalities, such as beta-blockers and angiotensin-converting enzyme inhibitors, improve survival. Whether antithrombotic treatment is effective remains to be elucidated, although observations suggest a prothrombotic state in heart failure. This article focuses on this prothrombotic state and discusses the risk of thromboembolic events, pathophysiological mechanisms, and the potential role of anticoagulant treatment.

U2 - 10.1055/s-0029-1234145

DO - 10.1055/s-0029-1234145

M3 - Journal article

C2 - 19739040

VL - 35

SP - 497

EP - 504

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

IS - 5

ER -

ID: 20320180